Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-8.96%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-8.96%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
Neurosense Therapeutics Ltd fundamental performance
Across Neurosense Therapeutics Ltd's full reported history, from 2021 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 4M to -$ 11M. Revenue increased in 0% of the years measured; net income in 25%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-13 | $ 0.44 | — |
1 Year2025-08-13 | $ 1.25 | -64.55% |
All Time2021-12-09 | $ 4.04 | -89.03% |
| Period | Last Price2026-08-13 | 1 Year2025-08-13 | All Time2021-12-09 |
|---|---|---|---|
| Price | $ 0.44 | $ 1.25 | $ 4.04 |
| Return | — | -64.55% | -89.03% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 0.00 | -$ 11M | $ 166K |
| 2024 | $ 0.00 | -$ 10M | $ 3M |
| 2023 | $ 0.00 | -$ 10M | $ 2M |
| 2022 | $ 0.00 | -$ 12M | $ 7M |
| IPO2021 | $ 0.00 | -$ 4M | $ 11M |
Explore beyond NRSN
You're looking at Neurosense Therapeutics Ltd. Members apply the same fundamental framework across all 3,859 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,859 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
